- Home
- WNC vs AVIR Comparison
WNC vs AVIR Comparison
Compare WNC & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WNC | AVIR |
|---|---|---|
| Founded | 1985 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Construction/Ag Equipment/Trucks | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 392.2M | 450.9M |
| IPO Year | 2009 | 2020 |
Fundamental Metrics
Financial Performance| Metric | WNC | AVIR |
|---|---|---|
| Price | $7.56 | $5.60 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $11.00 | $10.00 |
| AVG Volume (30 Days) | ★ 633.6K | 250.9K |
| Earning Date | 05-01-2026 | 05-11-2026 |
| Dividend Yield | ★ 3.84% | N/A |
| EPS Growth | ★ 179.22 | 3.00 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,027,489,000.00 | $351,367,000.00 |
| Revenue This Year | $10.65 | N/A |
| Revenue Next Year | $14.06 | N/A |
| P/E Ratio | $1.50 | ★ N/A |
| Revenue Growth | ★ 8.81 | N/A |
| 52 Week Low | $7.10 | $2.46 |
| 52 Week High | $12.94 | $6.45 |
Technical Indicators
Market Signals| Indicator | WNC | AVIR |
|---|---|---|
| Relative Strength Index (RSI) | 34.55 | 50.29 |
| Support Level | N/A | $3.28 |
| Resistance Level | $9.48 | $6.37 |
| Average True Range (ATR) | 0.49 | 0.22 |
| MACD | -0.11 | -0.04 |
| Stochastic Oscillator | 19.57 | 48.65 |
Price Performance
Historical ComparisonAbout WNC Wabash National Corporation
Wabash National Corp operates as the innovation leader of connected solutions for the transportation, logistics, and distribution industries. The Company manages its business in two operating and reportable segments: Transportation Solutions and Parts & Services. It designs and manufactures products including dry freight and refrigerated trailers, platform trailers, tank trailers, dry and refrigerated truck bodies, structural composite panels and products, trailer aerodynamic solutions, and specialty food-grade processing equipment.
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.